Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression (original) (raw)
Navab R, Strumpf D, Bandarchi B, Zhu CQ, Pintilie M, Ramnarine VR et al. Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proc Natl Acad Sci USA 2011; 108: 7160–7165. ArticleCAS Google Scholar
Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11–30. Article Google Scholar
Kozu Y, Maniwa T, Takahashi S, Isaka M, Ohde Y, Nakajima T . Risk factors for both recurrence and survival in patients with pathological stage I non-small-cell lung cancer. Eur J Cardiothorac Surg 2013; 44: e53–e58. Article Google Scholar
Hung JJ, Jeng WJ, Chou TY, Hsu WH, Wu KJ, Huang BS et al. Prognostic value of the new international association for the study of lung cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma. Ann Surg 2013; 258: 1079–1086. Article Google Scholar
Reck M, Heigener DF, Mok T, Soria JC, Rabe KF . Management of non-small-cell lung cancer: recent developments. Lancet 2013; 382: 709–719. ArticleCAS Google Scholar
Troyanovsky B, Levchenko T, Månsson G, Matvijenko O, Holmgren L . Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 2001; 152: 1247–1254. ArticleCAS Google Scholar
Bratt A, Birot O, Sinha I, Veitonmäki N, Aase K, Ernkvist M et al. Angiomotin regulates endothelial cell-cell junctions and cell motility. J Biol Chem 2005; 280: 34859–34869. ArticleCAS Google Scholar
Dai X, She P, Chi F, Feng Y, Liu H, Jin D et al. Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration and angiogenesis. J Biol Chem 2013; 288: 34041–34051. ArticleCAS Google Scholar
Moleirinho S, Guerrant W, Kissil JL . The Angiomotins - from discovery to function. FEBS Lett 2014; 588: 2693–2703. ArticleCAS Google Scholar
Wells CD, Fawcett JP, Traweger A, Yamanaka Y, Goudreault M, Elder K et al. A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells. Cell 2006; 125: 535–548. ArticleCAS Google Scholar
Yi C, Troutman S, Fera D, Stemmer-Rachamimov A, Avila JL, Christian N et al. A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions. Cancer Cell 2011; 19: 527–540. ArticleCAS Google Scholar
Ranahan WP, Han Z, Smith-Kinnaman W, Nabinger SC, Heller B, Herbert BS et al. The adaptor protein AMOT promotes the proliferation of mammary epithelial cells via the prolonged activation of the extracellular signal-regulated kinases. Cancer Res 2011; 71: 2203–2211. ArticleCAS Google Scholar
Adler JJ, Johnson DE, Heller BL, Bringman LR, Ranahan WP, Conwell MD et al. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases. Proc Natl Acad Sci USA 2013; 110: 17368–17373. ArticleCAS Google Scholar
Park HW, Guan KL . Regulation of the Hippo pathway and implications for anti-cancer drug development. Trends Pharmacol Sci 2013; 34: 581–589. ArticleCAS Google Scholar
Zhou Z, Hao Y, Liu N, Raptis L, Tsao MS, Yang X . TAZ is a novel oncogene in non-small cell lung cancer. Oncogene 2011; 30: 2181–2186. ArticleCAS Google Scholar
Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz M et al. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J 2000; 19: 6778–6791. ArticleCAS Google Scholar
Sudol M, Bork P, Einbond A, Kastury K, Druck T, Negrini M et al. Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain. J Biol Chem 1995; 270: 14733–14741. ArticleCAS Google Scholar
Wang Y, Dong Q, Zhang Q, Li Z, Wang E, Qiu X . Over-expression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci 2010; 101: 1279–1278. ArticleCAS Google Scholar
Zhi X, Zhao D, Zhou Z, Liu R, Chen C . YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor. Am J Pathol 2012; 180: 2452–2461. ArticleCAS Google Scholar
Yi C, Shen Z, Stemmer-Rachamimov A, Dawany N, Troutman S, Showe LC et al. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis. Sci Signal 2013; 6: ra77. Article Google Scholar
Oka T, Schmitt AP, Sudol M . Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP. Oncogene 2012; 31: 128–134. ArticleCAS Google Scholar
Paramasivam M, Sarkeshik A, Yates JR 3rd, Fernandes MJ, McCollum D . Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol Biol Cell 2011; 22: 3725–3733. ArticleCAS Google Scholar
Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, Hong W . Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem 2011; 286: 7018–7026. ArticleCAS Google Scholar
Hsu YL, Wu CY, Hung JY, Lin YS, Huang MS, Kuo PL . Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway. Carcinogenesis 2013; 34: 1370–1381. ArticleCAS Google Scholar
Kao YR, Shih JY, Wen WC, Ko YP, Chen BM, Chan YL et al. Tumor-associated antigen L6 and the invasion of human lung cancer cells. Clin Cancer Res 2003; 9: 2807–2816. CASPubMed Google Scholar
Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix MJ, Wu R et al. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 1997; 17: 353–360. ArticleCAS Google Scholar
Shih JY, Yang PC . The EMT regulator slug and lung carcinogenesis. Carcinogenesis 2011; 32: 1299–1304. ArticleCAS Google Scholar
Moreno-Bueno G, Portillo F, Cano A . Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008; 27: 6958–6969. ArticleCAS Google Scholar
Zhang H, Pasolli HA, Fuchs E . Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin. Proc Natl Acad Sci USA 2011; 108: 2270–2275. ArticleCAS Google Scholar
Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 2012; 150: 780–791. ArticleCAS Google Scholar
Holmgren L, Ambrosino E, Birot O, Tullus C, Veitonmäki N, Levchenko T et al. DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. Proc Natl Acad Sci USA 2006; 103: 9208–9213. ArticleCAS Google Scholar
Arigoni M, Barutello G, Lanzardo S, Longo D, Aime S, Curcio C et al. A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. Angiogenesis 2012; 15: 305–316. ArticleCAS Google Scholar
Ernkvist M, Birot O, Sinha I, Veitonmaki N, Nyström S, Aase K et al. Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells. Biochim Biophys Acta 2008; 1783: 429–437. ArticleCAS Google Scholar
Fanning AS, Van Itallie CM, Anderson JM . Zonula occludens-1 and -2 regulate apical cell structure and the zonula adherens cytoskeleton in polarized epithelia. Mol Biol Cell 2012; 23: 577–590. ArticleCAS Google Scholar
Mizuno T, Murakami H, Fujii M, Ishiguro F, Tanaka I, Kondo Y et al. YAP induces malignant mesothelioma cell proliferation by up-regulating transcription of cell cycle-promoting genes. Oncogene 2012; 31: 5117–5122. ArticleCAS Google Scholar
Muramatsu T, Imoto I, Matsui T, Kozaki K, Haruki S, Sudol M et al. YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis 2011; 32: 389–398. ArticleCAS Google Scholar
Wang L, Shi S, Guo Z, Zhang X, Han S, Yang A et al. Over-expression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. PLoS ONE 2013; 8: e65539. ArticleCAS Google Scholar
Su LL, Ma WX, Yuan JF, Shao Y, Xiao W, Jiang SJ . Expression of Yes-associated protein in non-small cell lung cancer and its relationship with clinical pathological factors. Chin Med J (Engl) 2012; 125: 4003–4008. CAS Google Scholar
Zhao B, Tumaneng K, Guan KL . The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 2011; 13: 877–883. ArticleCAS Google Scholar
Avruch J, Zhou D, Bardeesy N . YAP oncogene over-expression supercharges colon cancer proliferation. Cell Cycle 2012; 11: 1090–1096. ArticleCAS Google Scholar
Cai H, Xu Y . The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells. Cell Commun Signal 2013; 11: 31. ArticleCAS Google Scholar
Xu CM, Liu WW, Liu CJ, Wen C, Lu HF, Wan FS . Mst1 over-expression inhibited the growth of human non-small cell lung cancer in vitro and in vivo. Cancer Gene Ther 2013; 20: 453–460. ArticleCAS Google Scholar
Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 2011; 25: 51–63. Article Google Scholar
Pobbati AV, Hong W . Emerging roles of TEAD transcription factors and its co-activators in cancers. Cancer Biol Ther 2013; 14: 390–398. ArticleCAS Google Scholar
Chen PP, Li WJ, Wang Y, Zhao S, Li DY, Feng LY et al. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer. PLoS ONE 2007; 2: e534. Article Google Scholar
Harris LG, Pannell LK, Singh S, Samant RS, Shevde LA . Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated up-regulation of Cyr61. Oncogene 2012; 31: 3370–3380. ArticleCAS Google Scholar
Lin J, Huo R, Wang L, Zhou Z, Sun Y, Shen B. et al. A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo. Cancer Immunol Immunother 2012; 61: 677–687. ArticleCAS Google Scholar
Schütte U, Bisht S, Heukamp LC, Kebschull M, Florin A, Haarmann J et al. Hippo signaling mediates proliferation, invasiveness, and metastatic potential of clear cell renal cell carcinoma. Transl Oncol 2014; 7: 309–321. Article Google Scholar
Jandova J, Beyer TE, Meuillet EJ, Watts GS . The matrix protein CCN1/CYR61 is required for α(V)β5-mediated cancer cell migration. Cell Biochem Funct 2012; 30: 687–695. ArticleCAS Google Scholar
Wu DD, Zhang F, Hao F, Chun J, Xu X, Cui MZ . Matricellular protein Cyr61bridges lysophosphatidic acid and integrin pathways leading to cell migration. J Biol Chem 2014; 289: 5774–5783. ArticleCAS Google Scholar
Sun X, Fa P, Cui Z, Xia Y, Sun L, Li Z et al. The EDA-containing cellular fibronectin induces epithelial-mesenchymal transition in lung cancer cells through integrin α9β1-mediated activation of PI3-K/AKT and Erk1/2. Carcinogenesis 2014; 35: 184–191. ArticleCAS Google Scholar
Jones AC, Trujillo KA, Phillips GK, Fleet TM, Murton JK, Severns V et al. Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization. Prostate 2012; 72: 1159–1170. ArticleCAS Google Scholar